Medical Devices & Consumables
Global Percutaneous Ventricular Assist Units Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 607745
- Pages: 135
- Figures: 136
- Views: 1
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Percutaneous Ventricular Assist Units market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Abiomed (Johnson & Johnson's)
Supira Medical
Medtronic
Teleflex
LivaNova
Berlin Heart GmbH
Segment by Type
Insertion Percutaneous Ventricular Assist Units
Peripheral Percutaneous Ventricular Assist Units
Segment by Application
Hospital
Institution
Clinic
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Percutaneous Ventricular Assist Units study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Percutaneous Ventricular Assist Units market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Abiomed (Johnson & Johnson's)
Supira Medical
Medtronic
Teleflex
LivaNova
Berlin Heart GmbH
Segment by Type
Insertion Percutaneous Ventricular Assist Units
Peripheral Percutaneous Ventricular Assist Units
Segment by Application
Hospital
Institution
Clinic
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Percutaneous Ventricular Assist Units study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Percutaneous Ventricular Assist Units: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Percutaneous Ventricular Assist Units Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Insertion Percutaneous Ventricular Assist Units
1.2.3 Peripheral Percutaneous Ventricular Assist Units
1.3 Market Segmentation by Application
1.3.1 Global Percutaneous Ventricular Assist Units Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Institution
1.3.4 Clinic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Percutaneous Ventricular Assist Units Revenue Estimates and Forecasts 2020-2031
2.2 Global Percutaneous Ventricular Assist Units Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Percutaneous Ventricular Assist Units Sales Estimates and Forecasts 2020-2031
2.4 Global Percutaneous Ventricular Assist Units Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Percutaneous Ventricular Assist Units Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Percutaneous Ventricular Assist Units Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Insertion Percutaneous Ventricular Assist Units Market Size by Manufacturers
3.5.2 Peripheral Percutaneous Ventricular Assist Units Market Size by Manufacturers
3.6 Global Percutaneous Ventricular Assist Units Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Percutaneous Ventricular Assist Units Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Percutaneous Ventricular Assist Units Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Percutaneous Ventricular Assist Units Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Percutaneous Ventricular Assist Units Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Percutaneous Ventricular Assist Units Sales and Revenue by Type (2020-2031)
6.4 North America Percutaneous Ventricular Assist Units Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Percutaneous Ventricular Assist Units Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Percutaneous Ventricular Assist Units Sales and Revenue by Type (2020-2031)
7.4 Europe Percutaneous Ventricular Assist Units Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Percutaneous Ventricular Assist Units Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Percutaneous Ventricular Assist Units Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Percutaneous Ventricular Assist Units Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Percutaneous Ventricular Assist Units Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Percutaneous Ventricular Assist Units Sales and Revenue by Type (2020-2031)
9.4 Central and South America Percutaneous Ventricular Assist Units Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Percutaneous Ventricular Assist Units Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Percutaneous Ventricular Assist Units Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Percutaneous Ventricular Assist Units Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Percutaneous Ventricular Assist Units Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abiomed (Johnson & Johnson's)
11.1.1 Abiomed (Johnson & Johnson's) Corporation Information
11.1.2 Abiomed (Johnson & Johnson's) Business Overview
11.1.3 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Product Models, Descriptions and Specifications
11.1.4 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales by Product in 2024
11.1.6 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales by Application in 2024
11.1.7 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales by Geographic Area in 2024
11.1.8 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units SWOT Analysis
11.1.9 Abiomed (Johnson & Johnson's) Recent Developments
11.2 Supira Medical
11.2.1 Supira Medical Corporation Information
11.2.2 Supira Medical Business Overview
11.2.3 Supira Medical Percutaneous Ventricular Assist Units Product Models, Descriptions and Specifications
11.2.4 Supira Medical Percutaneous Ventricular Assist Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Supira Medical Percutaneous Ventricular Assist Units Sales by Product in 2024
11.2.6 Supira Medical Percutaneous Ventricular Assist Units Sales by Application in 2024
11.2.7 Supira Medical Percutaneous Ventricular Assist Units Sales by Geographic Area in 2024
11.2.8 Supira Medical Percutaneous Ventricular Assist Units SWOT Analysis
11.2.9 Supira Medical Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Percutaneous Ventricular Assist Units Product Models, Descriptions and Specifications
11.3.4 Medtronic Percutaneous Ventricular Assist Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic Percutaneous Ventricular Assist Units Sales by Product in 2024
11.3.6 Medtronic Percutaneous Ventricular Assist Units Sales by Application in 2024
11.3.7 Medtronic Percutaneous Ventricular Assist Units Sales by Geographic Area in 2024
11.3.8 Medtronic Percutaneous Ventricular Assist Units SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Teleflex
11.4.1 Teleflex Corporation Information
11.4.2 Teleflex Business Overview
11.4.3 Teleflex Percutaneous Ventricular Assist Units Product Models, Descriptions and Specifications
11.4.4 Teleflex Percutaneous Ventricular Assist Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Teleflex Percutaneous Ventricular Assist Units Sales by Product in 2024
11.4.6 Teleflex Percutaneous Ventricular Assist Units Sales by Application in 2024
11.4.7 Teleflex Percutaneous Ventricular Assist Units Sales by Geographic Area in 2024
11.4.8 Teleflex Percutaneous Ventricular Assist Units SWOT Analysis
11.4.9 Teleflex Recent Developments
11.5 LivaNova
11.5.1 LivaNova Corporation Information
11.5.2 LivaNova Business Overview
11.5.3 LivaNova Percutaneous Ventricular Assist Units Product Models, Descriptions and Specifications
11.5.4 LivaNova Percutaneous Ventricular Assist Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 LivaNova Percutaneous Ventricular Assist Units Sales by Product in 2024
11.5.6 LivaNova Percutaneous Ventricular Assist Units Sales by Application in 2024
11.5.7 LivaNova Percutaneous Ventricular Assist Units Sales by Geographic Area in 2024
11.5.8 LivaNova Percutaneous Ventricular Assist Units SWOT Analysis
11.5.9 LivaNova Recent Developments
11.6 Berlin Heart GmbH
11.6.1 Berlin Heart GmbH Corporation Information
11.6.2 Berlin Heart GmbH Business Overview
11.6.3 Berlin Heart GmbH Percutaneous Ventricular Assist Units Product Models, Descriptions and Specifications
11.6.4 Berlin Heart GmbH Percutaneous Ventricular Assist Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Berlin Heart GmbH Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Percutaneous Ventricular Assist Units Industry Chain
12.2 Percutaneous Ventricular Assist Units Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Percutaneous Ventricular Assist Units Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Percutaneous Ventricular Assist Units Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Percutaneous Ventricular Assist Units Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Percutaneous Ventricular Assist Units Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Percutaneous Ventricular Assist Units: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Percutaneous Ventricular Assist Units Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Insertion Percutaneous Ventricular Assist Units
1.2.3 Peripheral Percutaneous Ventricular Assist Units
1.3 Market Segmentation by Application
1.3.1 Global Percutaneous Ventricular Assist Units Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Institution
1.3.4 Clinic
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Percutaneous Ventricular Assist Units Revenue Estimates and Forecasts 2020-2031
2.2 Global Percutaneous Ventricular Assist Units Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Percutaneous Ventricular Assist Units Sales Estimates and Forecasts 2020-2031
2.4 Global Percutaneous Ventricular Assist Units Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Percutaneous Ventricular Assist Units Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Percutaneous Ventricular Assist Units Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Insertion Percutaneous Ventricular Assist Units Market Size by Manufacturers
3.5.2 Peripheral Percutaneous Ventricular Assist Units Market Size by Manufacturers
3.6 Global Percutaneous Ventricular Assist Units Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Percutaneous Ventricular Assist Units Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Percutaneous Ventricular Assist Units Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Percutaneous Ventricular Assist Units Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Percutaneous Ventricular Assist Units Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Percutaneous Ventricular Assist Units Sales and Revenue by Type (2020-2031)
6.4 North America Percutaneous Ventricular Assist Units Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Percutaneous Ventricular Assist Units Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Percutaneous Ventricular Assist Units Sales and Revenue by Type (2020-2031)
7.4 Europe Percutaneous Ventricular Assist Units Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Percutaneous Ventricular Assist Units Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Percutaneous Ventricular Assist Units Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Percutaneous Ventricular Assist Units Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Percutaneous Ventricular Assist Units Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Percutaneous Ventricular Assist Units Sales and Revenue by Type (2020-2031)
9.4 Central and South America Percutaneous Ventricular Assist Units Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Percutaneous Ventricular Assist Units Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Percutaneous Ventricular Assist Units Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Percutaneous Ventricular Assist Units Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Percutaneous Ventricular Assist Units Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abiomed (Johnson & Johnson's)
11.1.1 Abiomed (Johnson & Johnson's) Corporation Information
11.1.2 Abiomed (Johnson & Johnson's) Business Overview
11.1.3 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Product Models, Descriptions and Specifications
11.1.4 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales by Product in 2024
11.1.6 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales by Application in 2024
11.1.7 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units Sales by Geographic Area in 2024
11.1.8 Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units SWOT Analysis
11.1.9 Abiomed (Johnson & Johnson's) Recent Developments
11.2 Supira Medical
11.2.1 Supira Medical Corporation Information
11.2.2 Supira Medical Business Overview
11.2.3 Supira Medical Percutaneous Ventricular Assist Units Product Models, Descriptions and Specifications
11.2.4 Supira Medical Percutaneous Ventricular Assist Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Supira Medical Percutaneous Ventricular Assist Units Sales by Product in 2024
11.2.6 Supira Medical Percutaneous Ventricular Assist Units Sales by Application in 2024
11.2.7 Supira Medical Percutaneous Ventricular Assist Units Sales by Geographic Area in 2024
11.2.8 Supira Medical Percutaneous Ventricular Assist Units SWOT Analysis
11.2.9 Supira Medical Recent Developments
11.3 Medtronic
11.3.1 Medtronic Corporation Information
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Percutaneous Ventricular Assist Units Product Models, Descriptions and Specifications
11.3.4 Medtronic Percutaneous Ventricular Assist Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Medtronic Percutaneous Ventricular Assist Units Sales by Product in 2024
11.3.6 Medtronic Percutaneous Ventricular Assist Units Sales by Application in 2024
11.3.7 Medtronic Percutaneous Ventricular Assist Units Sales by Geographic Area in 2024
11.3.8 Medtronic Percutaneous Ventricular Assist Units SWOT Analysis
11.3.9 Medtronic Recent Developments
11.4 Teleflex
11.4.1 Teleflex Corporation Information
11.4.2 Teleflex Business Overview
11.4.3 Teleflex Percutaneous Ventricular Assist Units Product Models, Descriptions and Specifications
11.4.4 Teleflex Percutaneous Ventricular Assist Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Teleflex Percutaneous Ventricular Assist Units Sales by Product in 2024
11.4.6 Teleflex Percutaneous Ventricular Assist Units Sales by Application in 2024
11.4.7 Teleflex Percutaneous Ventricular Assist Units Sales by Geographic Area in 2024
11.4.8 Teleflex Percutaneous Ventricular Assist Units SWOT Analysis
11.4.9 Teleflex Recent Developments
11.5 LivaNova
11.5.1 LivaNova Corporation Information
11.5.2 LivaNova Business Overview
11.5.3 LivaNova Percutaneous Ventricular Assist Units Product Models, Descriptions and Specifications
11.5.4 LivaNova Percutaneous Ventricular Assist Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 LivaNova Percutaneous Ventricular Assist Units Sales by Product in 2024
11.5.6 LivaNova Percutaneous Ventricular Assist Units Sales by Application in 2024
11.5.7 LivaNova Percutaneous Ventricular Assist Units Sales by Geographic Area in 2024
11.5.8 LivaNova Percutaneous Ventricular Assist Units SWOT Analysis
11.5.9 LivaNova Recent Developments
11.6 Berlin Heart GmbH
11.6.1 Berlin Heart GmbH Corporation Information
11.6.2 Berlin Heart GmbH Business Overview
11.6.3 Berlin Heart GmbH Percutaneous Ventricular Assist Units Product Models, Descriptions and Specifications
11.6.4 Berlin Heart GmbH Percutaneous Ventricular Assist Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Berlin Heart GmbH Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Percutaneous Ventricular Assist Units Industry Chain
12.2 Percutaneous Ventricular Assist Units Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Percutaneous Ventricular Assist Units Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Percutaneous Ventricular Assist Units Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Percutaneous Ventricular Assist Units Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Percutaneous Ventricular Assist Units Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Percutaneous Ventricular Assist Units Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Percutaneous Ventricular Assist Units Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Percutaneous Ventricular Assist Units Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Percutaneous Ventricular Assist Units Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Percutaneous Ventricular Assist Units Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Percutaneous Ventricular Assist Units Sales by Region (2020-2025) & (K Units)
Table 8. Global Percutaneous Ventricular Assist Units Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Percutaneous Ventricular Assist Units Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Percutaneous Ventricular Assist Units Sales Share by Manufacturers (2020-2025)
Table 12. Global Percutaneous Ventricular Assist Units Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Percutaneous Ventricular Assist Units Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Percutaneous Ventricular Assist Units by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Ventricular Assist Units as of 2024)
Table 16. Global Percutaneous Ventricular Assist Units Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Percutaneous Ventricular Assist Units Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Percutaneous Ventricular Assist Units Manufacturing Base and Headquarters
Table 19. Global Percutaneous Ventricular Assist Units Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Percutaneous Ventricular Assist Units Sales by Type (2020-2025) & (K Units)
Table 23. Global Percutaneous Ventricular Assist Units Sales by Type (2026-2031) & (K Units)
Table 24. Global Percutaneous Ventricular Assist Units Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Percutaneous Ventricular Assist Units Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Percutaneous Ventricular Assist Units ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Percutaneous Ventricular Assist Units Sales by Application (2020-2025) & (K Units)
Table 29. Global Percutaneous Ventricular Assist Units Sales by Application (2026-2031) & (K Units)
Table 30. Percutaneous Ventricular Assist Units High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Percutaneous Ventricular Assist Units Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Percutaneous Ventricular Assist Units Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Percutaneous Ventricular Assist Units ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Percutaneous Ventricular Assist Units Growth Accelerators and Market Barriers
Table 37. North America Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Percutaneous Ventricular Assist Units Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Percutaneous Ventricular Assist Units Growth Accelerators and Market Barriers
Table 40. Europe Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Percutaneous Ventricular Assist Units Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Percutaneous Ventricular Assist Units Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Percutaneous Ventricular Assist Units Growth Accelerators and Market Barriers
Table 45. Southeast Asia Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Percutaneous Ventricular Assist Units Investment Opportunities and Key Challenges
Table 47. Central and South America Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Percutaneous Ventricular Assist Units Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Abiomed (Johnson & Johnson's) Corporation Information
Table 51. Abiomed (Johnson & Johnson's) Description and Major Businesses
Table 52. Abiomed (Johnson & Johnson's) Product Models, Descriptions and Specifications
Table 53. Abiomed (Johnson & Johnson's) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Abiomed (Johnson & Johnson's) Sales Value Proportion by Product in 2024
Table 55. Abiomed (Johnson & Johnson's) Sales Value Proportion by Application in 2024
Table 56. Abiomed (Johnson & Johnson's) Sales Value Proportion by Geographic Area in 2024
Table 57. Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units SWOT Analysis
Table 58. Abiomed (Johnson & Johnson's) Recent Developments
Table 59. Supira Medical Corporation Information
Table 60. Supira Medical Description and Major Businesses
Table 61. Supira Medical Product Models, Descriptions and Specifications
Table 62. Supira Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Supira Medical Sales Value Proportion by Product in 2024
Table 64. Supira Medical Sales Value Proportion by Application in 2024
Table 65. Supira Medical Sales Value Proportion by Geographic Area in 2024
Table 66. Supira Medical Percutaneous Ventricular Assist Units SWOT Analysis
Table 67. Supira Medical Recent Developments
Table 68. Medtronic Corporation Information
Table 69. Medtronic Description and Major Businesses
Table 70. Medtronic Product Models, Descriptions and Specifications
Table 71. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Medtronic Sales Value Proportion by Product in 2024
Table 73. Medtronic Sales Value Proportion by Application in 2024
Table 74. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 75. Medtronic Percutaneous Ventricular Assist Units SWOT Analysis
Table 76. Medtronic Recent Developments
Table 77. Teleflex Corporation Information
Table 78. Teleflex Description and Major Businesses
Table 79. Teleflex Product Models, Descriptions and Specifications
Table 80. Teleflex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Teleflex Sales Value Proportion by Product in 2024
Table 82. Teleflex Sales Value Proportion by Application in 2024
Table 83. Teleflex Sales Value Proportion by Geographic Area in 2024
Table 84. Teleflex Percutaneous Ventricular Assist Units SWOT Analysis
Table 85. Teleflex Recent Developments
Table 86. LivaNova Corporation Information
Table 87. LivaNova Description and Major Businesses
Table 88. LivaNova Product Models, Descriptions and Specifications
Table 89. LivaNova Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. LivaNova Sales Value Proportion by Product in 2024
Table 91. LivaNova Sales Value Proportion by Application in 2024
Table 92. LivaNova Sales Value Proportion by Geographic Area in 2024
Table 93. LivaNova Percutaneous Ventricular Assist Units SWOT Analysis
Table 94. LivaNova Recent Developments
Table 95. Berlin Heart GmbH Corporation Information
Table 96. Berlin Heart GmbH Description and Major Businesses
Table 97. Berlin Heart GmbH Product Models, Descriptions and Specifications
Table 98. Berlin Heart GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Berlin Heart GmbH Recent Developments
Table 100. Key Raw Materials Distribution
Table 101. Raw Materials Key Suppliers
Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 103. Milestones in Production Technology Evolution
Table 104. Distributors List
Table 105. Market Trends and Market Evolution
Table 106. Market Drivers and Opportunities
Table 107. Market Challenges, Risks, and Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Percutaneous Ventricular Assist Units Product Picture
Figure 2. Global Percutaneous Ventricular Assist Units Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Insertion Percutaneous Ventricular Assist Units Product Picture
Figure 4. Peripheral Percutaneous Ventricular Assist Units Product Picture
Figure 5. Global Percutaneous Ventricular Assist Units Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Institution
Figure 8. Clinic
Figure 9. Others
Figure 10. Percutaneous Ventricular Assist Units Report Years Considered
Figure 11. Global Percutaneous Ventricular Assist Units Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 13. Global Percutaneous Ventricular Assist Units Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Percutaneous Ventricular Assist Units Revenue Market Share by Region (2020-2031)
Figure 15. Global Percutaneous Ventricular Assist Units Sales (2020-2031) & (K Units)
Figure 16. Global Percutaneous Ventricular Assist Units Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Percutaneous Ventricular Assist Units Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Percutaneous Ventricular Assist Units Sales Volume Market Share in 2024
Figure 19. Global Percutaneous Ventricular Assist Units Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Insertion Percutaneous Ventricular Assist Units Revenue Market Share by Manufacturer in 2024
Figure 22. Peripheral Percutaneous Ventricular Assist Units Revenue Market Share by Manufacturer in 2024
Figure 23. Global Percutaneous Ventricular Assist Units Sales Market Share by Type (2020-2031)
Figure 24. Global Percutaneous Ventricular Assist Units Revenue Market Share by Type (2020-2031)
Figure 25. Global Percutaneous Ventricular Assist Units Sales Market Share by Application (2020-2031)
Figure 26. Global Percutaneous Ventricular Assist Units Revenue Market Share by Application (2020-2031)
Figure 27. North America Percutaneous Ventricular Assist Units Sales YoY (2020-2031) & (K Units)
Figure 28. North America Percutaneous Ventricular Assist Units Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) in 2024
Figure 30. North America Percutaneous Ventricular Assist Units Sales Volume (K Units) by Type (2020- 2031)
Figure 31. North America Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Percutaneous Ventricular Assist Units Sales Volume (K Units) by Application (2020-2031)
Figure 33. North America Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Percutaneous Ventricular Assist Units Sales YoY (2020-2031) & (K Units)
Figure 38. Europe Percutaneous Ventricular Assist Units Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) in 2024
Figure 40. Europe Percutaneous Ventricular Assist Units Sales Volume (K Units) by Type (2020-2031)
Figure 41. Europe Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Percutaneous Ventricular Assist Units Sales Volume (K Units) by Application (2020-2031)
Figure 43. Europe Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 45. France Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Percutaneous Ventricular Assist Units Sales YoY (2020-2031) & (K Units)
Figure 50. Asia-Pacific Percutaneous Ventricular Assist Units Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Percutaneous Ventricular Assist Units Sales Volume (K Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Percutaneous Ventricular Assist Units Sales Volume (K Units) by Application (2020-2031)
Figure 55. Asia-Pacific Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 60. India Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Percutaneous Ventricular Assist Units Sales YoY (2020-2031) & (K Units)
Figure 62. Central and South America Percutaneous Ventricular Assist Units Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Percutaneous Ventricular Assist Units Sales Volume (K Units) by Type (2021-2031)
Figure 65. Central and South America Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Percutaneous Ventricular Assist Units Sales Volume (K Units) by Application (2020-2031)
Figure 67. Central and South America Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Percutaneous Ventricular Assist Units Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Percutaneous Ventricular Assist Units Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Percutaneous Ventricular Assist Units Sales YoY (2020-2031) & (K Units)
Figure 71. Middle East and Africa Percutaneous Ventricular Assist Units Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Percutaneous Ventricular Assist Units Sales Volume (K Units) by Type (2021-2031)
Figure 74. South America Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Percutaneous Ventricular Assist Units Sales Volume (K Units) by Application (2020-2031)
Figure 76. Middle East and Africa Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Percutaneous Ventricular Assist Units Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Percutaneous Ventricular Assist Units Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Percutaneous Ventricular Assist Units Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Percutaneous Ventricular Assist Units Revenue (2020-2025) & (US$ Million)
Figure 81. Percutaneous Ventricular Assist Units Industry Chain Mapping
Figure 82. Regional Percutaneous Ventricular Assist Units Manufacturing Base Distribution (%)
Figure 83. Global Percutaneous Ventricular Assist Units Production Market Share by Region (2020-2031)
Figure 84. Percutaneous Ventricular Assist Units Production Process
Figure 85. Regional Percutaneous Ventricular Assist Units Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Table 1. Global Percutaneous Ventricular Assist Units Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Percutaneous Ventricular Assist Units Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Percutaneous Ventricular Assist Units Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Percutaneous Ventricular Assist Units Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Percutaneous Ventricular Assist Units Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Percutaneous Ventricular Assist Units Sales by Region (2020-2025) & (K Units)
Table 8. Global Percutaneous Ventricular Assist Units Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Percutaneous Ventricular Assist Units Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Percutaneous Ventricular Assist Units Sales Share by Manufacturers (2020-2025)
Table 12. Global Percutaneous Ventricular Assist Units Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Percutaneous Ventricular Assist Units Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Percutaneous Ventricular Assist Units by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Percutaneous Ventricular Assist Units as of 2024)
Table 16. Global Percutaneous Ventricular Assist Units Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Percutaneous Ventricular Assist Units Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Percutaneous Ventricular Assist Units Manufacturing Base and Headquarters
Table 19. Global Percutaneous Ventricular Assist Units Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Percutaneous Ventricular Assist Units Sales by Type (2020-2025) & (K Units)
Table 23. Global Percutaneous Ventricular Assist Units Sales by Type (2026-2031) & (K Units)
Table 24. Global Percutaneous Ventricular Assist Units Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Percutaneous Ventricular Assist Units Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Percutaneous Ventricular Assist Units ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Percutaneous Ventricular Assist Units Sales by Application (2020-2025) & (K Units)
Table 29. Global Percutaneous Ventricular Assist Units Sales by Application (2026-2031) & (K Units)
Table 30. Percutaneous Ventricular Assist Units High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Percutaneous Ventricular Assist Units Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Percutaneous Ventricular Assist Units Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Percutaneous Ventricular Assist Units ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Percutaneous Ventricular Assist Units Growth Accelerators and Market Barriers
Table 37. North America Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Percutaneous Ventricular Assist Units Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Percutaneous Ventricular Assist Units Growth Accelerators and Market Barriers
Table 40. Europe Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Percutaneous Ventricular Assist Units Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Percutaneous Ventricular Assist Units Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Percutaneous Ventricular Assist Units Growth Accelerators and Market Barriers
Table 45. Southeast Asia Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Percutaneous Ventricular Assist Units Investment Opportunities and Key Challenges
Table 47. Central and South America Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Percutaneous Ventricular Assist Units Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Percutaneous Ventricular Assist Units Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Abiomed (Johnson & Johnson's) Corporation Information
Table 51. Abiomed (Johnson & Johnson's) Description and Major Businesses
Table 52. Abiomed (Johnson & Johnson's) Product Models, Descriptions and Specifications
Table 53. Abiomed (Johnson & Johnson's) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Abiomed (Johnson & Johnson's) Sales Value Proportion by Product in 2024
Table 55. Abiomed (Johnson & Johnson's) Sales Value Proportion by Application in 2024
Table 56. Abiomed (Johnson & Johnson's) Sales Value Proportion by Geographic Area in 2024
Table 57. Abiomed (Johnson & Johnson's) Percutaneous Ventricular Assist Units SWOT Analysis
Table 58. Abiomed (Johnson & Johnson's) Recent Developments
Table 59. Supira Medical Corporation Information
Table 60. Supira Medical Description and Major Businesses
Table 61. Supira Medical Product Models, Descriptions and Specifications
Table 62. Supira Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Supira Medical Sales Value Proportion by Product in 2024
Table 64. Supira Medical Sales Value Proportion by Application in 2024
Table 65. Supira Medical Sales Value Proportion by Geographic Area in 2024
Table 66. Supira Medical Percutaneous Ventricular Assist Units SWOT Analysis
Table 67. Supira Medical Recent Developments
Table 68. Medtronic Corporation Information
Table 69. Medtronic Description and Major Businesses
Table 70. Medtronic Product Models, Descriptions and Specifications
Table 71. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Medtronic Sales Value Proportion by Product in 2024
Table 73. Medtronic Sales Value Proportion by Application in 2024
Table 74. Medtronic Sales Value Proportion by Geographic Area in 2024
Table 75. Medtronic Percutaneous Ventricular Assist Units SWOT Analysis
Table 76. Medtronic Recent Developments
Table 77. Teleflex Corporation Information
Table 78. Teleflex Description and Major Businesses
Table 79. Teleflex Product Models, Descriptions and Specifications
Table 80. Teleflex Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Teleflex Sales Value Proportion by Product in 2024
Table 82. Teleflex Sales Value Proportion by Application in 2024
Table 83. Teleflex Sales Value Proportion by Geographic Area in 2024
Table 84. Teleflex Percutaneous Ventricular Assist Units SWOT Analysis
Table 85. Teleflex Recent Developments
Table 86. LivaNova Corporation Information
Table 87. LivaNova Description and Major Businesses
Table 88. LivaNova Product Models, Descriptions and Specifications
Table 89. LivaNova Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. LivaNova Sales Value Proportion by Product in 2024
Table 91. LivaNova Sales Value Proportion by Application in 2024
Table 92. LivaNova Sales Value Proportion by Geographic Area in 2024
Table 93. LivaNova Percutaneous Ventricular Assist Units SWOT Analysis
Table 94. LivaNova Recent Developments
Table 95. Berlin Heart GmbH Corporation Information
Table 96. Berlin Heart GmbH Description and Major Businesses
Table 97. Berlin Heart GmbH Product Models, Descriptions and Specifications
Table 98. Berlin Heart GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Berlin Heart GmbH Recent Developments
Table 100. Key Raw Materials Distribution
Table 101. Raw Materials Key Suppliers
Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 103. Milestones in Production Technology Evolution
Table 104. Distributors List
Table 105. Market Trends and Market Evolution
Table 106. Market Drivers and Opportunities
Table 107. Market Challenges, Risks, and Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Percutaneous Ventricular Assist Units Product Picture
Figure 2. Global Percutaneous Ventricular Assist Units Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Insertion Percutaneous Ventricular Assist Units Product Picture
Figure 4. Peripheral Percutaneous Ventricular Assist Units Product Picture
Figure 5. Global Percutaneous Ventricular Assist Units Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Institution
Figure 8. Clinic
Figure 9. Others
Figure 10. Percutaneous Ventricular Assist Units Report Years Considered
Figure 11. Global Percutaneous Ventricular Assist Units Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 13. Global Percutaneous Ventricular Assist Units Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Percutaneous Ventricular Assist Units Revenue Market Share by Region (2020-2031)
Figure 15. Global Percutaneous Ventricular Assist Units Sales (2020-2031) & (K Units)
Figure 16. Global Percutaneous Ventricular Assist Units Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Percutaneous Ventricular Assist Units Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Percutaneous Ventricular Assist Units Sales Volume Market Share in 2024
Figure 19. Global Percutaneous Ventricular Assist Units Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Insertion Percutaneous Ventricular Assist Units Revenue Market Share by Manufacturer in 2024
Figure 22. Peripheral Percutaneous Ventricular Assist Units Revenue Market Share by Manufacturer in 2024
Figure 23. Global Percutaneous Ventricular Assist Units Sales Market Share by Type (2020-2031)
Figure 24. Global Percutaneous Ventricular Assist Units Revenue Market Share by Type (2020-2031)
Figure 25. Global Percutaneous Ventricular Assist Units Sales Market Share by Application (2020-2031)
Figure 26. Global Percutaneous Ventricular Assist Units Revenue Market Share by Application (2020-2031)
Figure 27. North America Percutaneous Ventricular Assist Units Sales YoY (2020-2031) & (K Units)
Figure 28. North America Percutaneous Ventricular Assist Units Revenue YoY (2020-2031) & (US$ Million)
Figure 29. North America Top 5 Manufacturers Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) in 2024
Figure 30. North America Percutaneous Ventricular Assist Units Sales Volume (K Units) by Type (2020- 2031)
Figure 31. North America Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 32. North America Percutaneous Ventricular Assist Units Sales Volume (K Units) by Application (2020-2031)
Figure 33. North America Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Percutaneous Ventricular Assist Units Sales YoY (2020-2031) & (K Units)
Figure 38. Europe Percutaneous Ventricular Assist Units Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Europe Top 5 Manufacturers Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) in 2024
Figure 40. Europe Percutaneous Ventricular Assist Units Sales Volume (K Units) by Type (2020-2031)
Figure 41. Europe Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Type (2020-2031)
Figure 42. Europe Percutaneous Ventricular Assist Units Sales Volume (K Units) by Application (2020-2031)
Figure 43. Europe Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. Germany Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 45. France Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 46. U.K. Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 47. Italy Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 48. Russia Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 49. Asia-Pacific Percutaneous Ventricular Assist Units Sales YoY (2020-2031) & (K Units)
Figure 50. Asia-Pacific Percutaneous Ventricular Assist Units Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Top 8 Manufacturers Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) in 2024
Figure 52. Asia-Pacific Percutaneous Ventricular Assist Units Sales Volume (K Units) by Type (2020- 2031)
Figure 53. Asia-Pacific Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 54. Asia-Pacific Percutaneous Ventricular Assist Units Sales Volume (K Units) by Application (2020-2031)
Figure 55. Asia-Pacific Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Application (2020-2031)
Figure 56. Indonesia Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 57. Japan Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 58. South Korea Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 59. China Taiwan Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 60. India Percutaneous Ventricular Assist Units Revenue (2020-2031) & (US$ Million)
Figure 61. Central and South America Percutaneous Ventricular Assist Units Sales YoY (2020-2031) & (K Units)
Figure 62. Central and South America Percutaneous Ventricular Assist Units Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Central and South America Top 5 Manufacturers Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) in 2024
Figure 64. Central and South America Percutaneous Ventricular Assist Units Sales Volume (K Units) by Type (2021-2031)
Figure 65. Central and South America Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Type (2020-2031)
Figure 66. Central and South America Percutaneous Ventricular Assist Units Sales Volume (K Units) by Application (2020-2031)
Figure 67. Central and South America Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Application (2020-2031)
Figure 68. Brazil Percutaneous Ventricular Assist Units Revenue (2020-2025) & (US$ Million)
Figure 69. Argentina Percutaneous Ventricular Assist Units Revenue (2020-2025) & (US$ Million)
Figure 70. Middle East, and Africa Percutaneous Ventricular Assist Units Sales YoY (2020-2031) & (K Units)
Figure 71. Middle East and Africa Percutaneous Ventricular Assist Units Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Manufacturers Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) in 2024
Figure 73. Middle East and Africa Percutaneous Ventricular Assist Units Sales Volume (K Units) by Type (2021-2031)
Figure 74. South America Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Type (2020-2031)
Figure 75. Middle East and Africa Percutaneous Ventricular Assist Units Sales Volume (K Units) by Application (2020-2031)
Figure 76. Middle East and Africa Percutaneous Ventricular Assist Units Sales Revenue (US$ Million) by Application (2020-2031)
Figure 77. GCC Countries Percutaneous Ventricular Assist Units Revenue (2020-2025) & (US$ Million)
Figure 78. Turkey Percutaneous Ventricular Assist Units Revenue (2020-2025) & (US$ Million)
Figure 79. Egypt Percutaneous Ventricular Assist Units Revenue (2020-2025) & (US$ Million)
Figure 80. South Africa Percutaneous Ventricular Assist Units Revenue (2020-2025) & (US$ Million)
Figure 81. Percutaneous Ventricular Assist Units Industry Chain Mapping
Figure 82. Regional Percutaneous Ventricular Assist Units Manufacturing Base Distribution (%)
Figure 83. Global Percutaneous Ventricular Assist Units Production Market Share by Region (2020-2031)
Figure 84. Percutaneous Ventricular Assist Units Production Process
Figure 85. Regional Percutaneous Ventricular Assist Units Production Cost Structure
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Wireless Split Keyboard Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Ergonomic Adjustable Computer Chair Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Trackless Keyboard Tray Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232